Tricyclic indole derivatives and their use in the treatment of alzheimer's disease

Details for Australian Patent Application No. 2004232475 (hide)

Owner Glaxo Group Limited

Inventors Redshaw, Sally; Walter, Daryl Simon; Demont, Emmanuel Hubert

Agent Davies Collison Cave

Pub. Number AU-B-2004232475

PCT Pub. Number WO2004/094430

Priority 0309221.0 23.04.03 GB

Filing date 21 April 2004

Wipo publication date 4 November 2004

Acceptance publication date 1 March 2007

International Classifications

C07D 487/06 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 513/06 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

27 October 2005 PCT application entered the National Phase

  PCT publication WO2004/094430 Priority application(s): WO2004/094430

1 March 2007 Application Accepted

  Published as AU-B-2004232475

28 June 2007 Standard Patent Sealed

19 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004232476

2004232462-8$g(b)-vinyl-11$g(b)-($g(v)-substituted) alkyl-estra-1,3,5(10)-trienes